Sidney M. Hecht is the director for the Center for BioEnergetics in the Biodesign Institute at Arizona State University. He researches diseases caused by defects in the body's energy production processes. Energy production is similar mechanistically to other molecular processes that he has studied extensively. He played a key role in the development of Hycamtin, a drug used to treat ovarian and lung cancer, as well as the study of the mechanism of the anti-tumor agent bleomycin.
In a career spanning more than three decades, Professor Hecht has held both academic and industrial research positions. He joins ASU from the University of Virginia, where he was a professor of both chemistry and biology. From 1981 to 1987, he concurrently held leadership positions in research and development for Smith Kline and French Laboratories. Prior to his 28 years at the University of Virginia, he was a faculty member at MIT. Hecht is the co-founder of Edison Pharmaceuticals, a pharmaceutical company focusing on inherited mitochondrial disorders. He earned a B.A. in chemistry from the University of Rochester and a Ph.D. in chemistry with emphasis in biochemistry from the University of Illinois.
Energy production is similar mechanistically to other molecular processes that are studied extensively. Hecht played a key role in the development of Hycamtin, a drug used to treat ovarian and lung cancer, as well as the study of the mechanism of the anti-tumor agent bleomycin. In a career spanning more than three decades, Hecht has held both academic and industrial research positions. He joins ASU from the University of Virginia, where he was a professor of both chemistry and biology. From 1981 to 1987, he concurrently held leadership positions in research and development for Smith Kline and French Laboratories. Prior to his 28 years at the University of Virginia, he was a faculty member at MIT. Hecht is the co-founder of Edison Pharmaceuticals, a pharmaceutical company focusing on inherited mitochondrial disorders. He earned a BA in chemistry from the University of Rochester and a PhD in chemistry with emphasis in biochemistry from the University of Illinois.
Fall 2020 | |
---|---|
Course Number | Course Title |
MBB 493 | Honors Thesis |
BIO 495 | Undergraduate Research |
NAN 598 | Special Topics |
CHM 598 | Special Topics |
BCH 598 | Special Topics |
Summer 2020 | |
---|---|
Course Number | Course Title |
BIO 495 | Undergraduate Research |
Fall 2019 | |
---|---|
Course Number | Course Title |
MBB 493 | Honors Thesis |
BIO 495 | Undergraduate Research |
NAN 598 | Special Topics |
CHM 598 | Special Topics |
BCH 598 | Special Topics |
Summer 2019 | |
---|---|
Course Number | Course Title |
BIO 495 | Undergraduate Research |
Fall 2018 | |
---|---|
Course Number | Course Title |
MBB 493 | Honors Thesis |
BIO 495 | Undergraduate Research |
BCH 598 | Special Topics |
CHM 598 | Special Topics |
Summer 2018 | |
---|---|
Course Number | Course Title |
BIO 495 | Undergraduate Research |
Fall 2017 | |
---|---|
Course Number | Course Title |
MBB 493 | Honors Thesis |
BIO 495 | Undergraduate Research |
NAN 598 | Special Topics |
CHM 598 | Special Topics |
BCH 598 | Special Topics |
Summer 2017 | |
---|---|
Course Number | Course Title |
BIO 495 | Undergraduate Research |
Fall 2016 | |
---|---|
Course Number | Course Title |
MBB 493 | Honors Thesis |
BIO 495 | Undergraduate Research |
NAN 598 | Special Topics |
CHM 598 | Special Topics |
BCH 598 | Special Topics |
Summer 2016 | |
---|---|
Course Number | Course Title |
BIO 495 | Undergraduate Research |